★ Sign in to follow
RH

Ryan H. Saadi

CEO
US·SEC (Form 4)
Tevogen Inc.
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
12
Company
1
▲ Purchases (1 ops.)
€1,839
▼ Sales (1 ops.)
€1.5M

Latest filing published 04 Nov 2026 for Tevogen Inc..

Filing timeline

BuySale
Ryan H. Saadi

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Tevogen Inc.
    Filed 07 Jun 2024 · 884 days ago · €1,839
    +32.9%
    Entry US$41.40 · Close at T+365 US$55.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Ryan H. Saadi: trading record in brief

All filings by Ryan H. Saadi on record concern Tevogen Inc. We count 12 filings; the first trade dates from 14 February 2024 and the latest from 2 November 2026.

On the open market, the record shows 1 purchase worth €1,839 and 1 sale worth €1.5M. On balance, insiders were net sellers of €1.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 7 share grants.

On 4 November 2026 came the latest disclosure, a share grant in Tevogen Inc. The most recent open-market purchase was published on 7 June 2024, 884 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ryan H. Saadi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    50,000,000 shares0Common StockSEC:0001493152-26-049968:0
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    8,000,000 shares0Common StockSEC:0001123292-26-001313:0
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    1,220,000 shares0Common StockSEC:0001123292-26-000995:0
  • ●
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    50,000 shares0Common StockSEC:0001123292-25-000765:0
  • ●
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    460,000 shares0Common StockSEC:0001123292-25-000755:0
  • ●
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    20,000 shares0Common StockSEC:0001062993-25-014586:0
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    8,000,000 shares0Common StockSEC:0001062993-25-012333:0
  • ▼
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    2M USD30SEC
    1,438,206 shares@ US$1.2399.9% of flowCommon StockSEC:0001062993-25-011293:0
  • ▲
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    2,000 USD22SEC
    2,607.322 shares@ US$0.76710.1% of flowCommon StockSEC:0001062993-24-012192:0
    Canonical exit: 3 Sept 2024 (T+90)
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    19,348,954 shares0Common StockSEC:0001062993-24-003494:1
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    193,923 sharesCommon StockSEC:0001062993-24-003494:2
  • ◆
    Ryan H. Saadi
    Chief Executive OfficerExecutivesTevogen Inc.
    0SEC
    98,901,098 sharesCommon StockSEC:0001062993-24-003494:0

12 of 12 declarations

Related entities

No related entities found.